MedTrace Logo

Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver Transplant

NCT01619449 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-05-27

No results posted yet for this study

Summary

To evaluate the efficacy of continuous renal replacement therapy (CRRT) during orthotopic liver transplantation (OLT) in clearing excess solutes and improving acid-base parameters. The investigators hypothesize that the use of intra-operative CRRT in OLT recipients is associated with increased solute removal and improved acid-base statues when compared to controls who do not receive CRRT

Conditions

Interventions

PROCEDURE

Renal replacement therapy

Liver transplant recipients receiving continuous renal replacement therapy for duration of liver transplant surgery.

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Jay L Koyner, MD · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01619449 on ClinicalTrials.gov